Patent · US Active

Composition for inhibiting after-cataract and method of preparing the same

US9364552B2 · kind B2 · utility

1Cited by
1References
16Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJan 9, 2012
Grant dateJun 14, 2016
Priority date
Expiry dateJan 9, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a composition for inhibiting after-cataract including a hydrophilic sulfasalazine; a high content of hyaluronic acid; and a carrier containing an aqueous solution, and a method of preparing a composition for inhibiting after-cataract including the steps of adding hyaluronic acid powder to a hydrophilized sulfasalazine; and mixing the same with a specific condition.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.